This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Washington University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2015
Title: Forbes Porter: Innovator in Cyclodextrin Therapy
Introduction
Forbes Porter is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of medical therapies, particularly in the area of cyclodextrin treatment for disorders involving oxysterol accumulation. His innovative approach has led to the development of methods that enhance the efficacy of cyclodextrin therapy.
Latest Patents
Forbes Porter holds 1 patent for his work titled "Methods of determining efficacy of cyclodextrin therapy." This patent discloses methods for assessing the effectiveness of cyclodextrin therapy in subjects afflicted with disorders related to oxysterol accumulation. The process involves obtaining body fluid samples before and after cyclodextrin administration, followed by chromatography-mass spectroscopy analysis to determine the concentration of specific compounds. The results help in evaluating the therapy's efficacy based on changes in these concentrations.
Career Highlights
Throughout his career, Forbes Porter has worked with prestigious institutions, including Washington University and the US National Institutes of Health. His research has focused on advancing therapeutic methods that can significantly impact patient care and treatment outcomes.
Collaborations
Forbes Porter has collaborated with notable professionals in his field, including Daniel S Ory. These partnerships have contributed to the development and refinement of his innovative therapies.
Conclusion
Forbes Porter is a distinguished inventor whose work in cyclodextrin therapy showcases his commitment to improving medical treatments. His contributions continue to influence the field and offer hope for patients dealing with complex disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile